Israel’s ministry has reportedly approved the use of pre-exposure prophylaxis (PrEP) drugs to prevent HIV infection.
Israeli news site Haaretz reports that Moshe Bar Siman Tov, Isreal’s ministry’s director general, accepted a HIV/AIDS subcommittee’s recommendation that PrEP medication regimes like Truvada be implemented in Israel.
The PrEP programs involves people at high risk taking daily medication that significantly reduces their risk of HIV infection.
“While anyone can be infected by HIV, we must not ignore the fact that men who have sex with other men are the group with a very high infection rate relative to its size,” Yuval Livnat, CEO of the country’s Aids Task Force, told Haaretz.
“Thus, there are some in the gay community who will be prevented from contracting infection by this treatment.”
The drug got the stamp of approval from the World Health Organisation last year, but is yet to be approved in many places.
In Australia, trials of the medication are underway. The Queensland government united with the state’s HIV organisations in mid-February to expand the Queensland trial.